Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 06:09 am Sale | 2010-02-28 | 13G | Sera Prognostics, Inc. SERA | INTERWEST PARTNERS X LP | 126,258 0.400% | -2,416,241 (-95.03%) | Filing History |
| 2023-02-10 1:00 pm Sale | 2010-02-28 | 13G | Braze, Inc. BRZE | INTERWEST PARTNERS X LP | 21,763 0.040% | -3,372,456 (-99.36%) | Filing History |
| 2023-02-10 1:00 pm Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 1,714,540 3.800% | -1,535,004 (-47.24%) | Filing History |
| 2023-02-10 1:00 pm Sale | 2010-02-28 | 13G | Doximity, Inc. DOCS | INTERWEST PARTNERS X LP | 3,005,268 2.600% | -6,031,690 (-66.74%) | Filing History |
| 2023-02-10 1:00 pm Unchanged | 2010-02-28 | 13G | Sera Prognostics, Inc. SERA | INTERWEST PARTNERS X LP | 2,542,499 8.500% | 0 (Unchanged) | Filing History |
| 2022-02-14 06:55 am Purchase | 2010-02-28 | 13G | Sera Prognostics, Inc. SERA | INTERWEST PARTNERS X LP | 2,542,499 8.600% | 2,542,499 (New Position) | Filing History |
| 2022-02-14 06:51 am Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 3,249,544 7.200% | -3,220,367 (-49.77%) | Filing History |
| 2022-02-14 06:50 am Purchase | 2010-02-28 | 13G | Doximity, Inc. DOCS | INTERWEST PARTNERS X LP | 9,036,958 7.900% | 9,036,958 (New Position) | Filing History |
| 2022-02-14 06:34 am Purchase | 2010-02-28 | 13G | Braze, Inc. BRZE | INTERWEST PARTNERS X LP | 3,394,219 25.400% | 3,394,219 (New Position) | Filing History |
| 2022-02-14 06:15 am Purchase | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 2 0.000% | 2 (New Position) | Filing History |
| 2021-08-11 7:27 pm Sale | 2021-08-03 | 13D | Cidara Therapeutics, Inc. CDTX | INTERWEST PARTNERS X LP | 45,187 1.900% | -22,654 (-33.39%) | Filing History |
| 2021-02-12 06:09 am Unchanged | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 46 5.100% | 0 (Unchanged) | Filing History |
| 2021-02-12 06:08 am Sale | 2010-02-28 | 13G | The RealReal, Inc. REAL | INTERWEST PARTNERS X LP | 3,860,343 4.400% | -2,847,737 (-42.45%) | Filing History |
| 2021-02-12 06:07 am Purchase | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 6,469,911 14.500% | 6,469,911 (New Position) | Filing History |
| 2020-02-14 07:05 am Purchase | 2010-02-28 | 13G | The RealReal, Inc. REAL | INTERWEST PARTNERS X LP | 6,708,080 7.800% | 6,708,080 (New Position) | Filing History |
| 2020-02-14 07:02 am Unchanged | 2010-02-28 | 13G | ReShape Lifesciences Inc. RSLS | INTERWEST PARTNERS X LP | 46 5.200% | 0 (Unchanged) | Filing History |